BioCentury
ARTICLE | Clinical News

Trumenba regulatory update

March 31, 2017 5:19 AM UTC

EMA's CHMP recommended approval of an MAA from Pfizer for Trumenba meningococcal group B vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals a...

BCIQ Company Profiles

Pfizer Inc.